Suppr超能文献

一种新型肺大体解剖方案对肺癌切除标本肺内淋巴结获取的影响。

The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.

作者信息

Osarogiagbon Raymond U, Eke Ransome, Sareen Srishti, Leary Cynthia, Coleman LaShundra, Faris Nicholas, Yu Xinhua, Spencer David

机构信息

Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, TN; Division of Epidemiology and Biostatistics, School of Public Health, University of Memphis, Memphis, TN.

Division of Epidemiology and Biostatistics, School of Public Health, University of Memphis, Memphis, TN.

出版信息

Ann Diagn Pathol. 2014 Aug;18(4):220-6. doi: 10.1016/j.anndiagpath.2014.03.005. Epub 2014 Apr 26.

Abstract

Although thorough pathologic nodal staging provides the greatest prognostic information in patients with potentially curable non-small cell lung cancer, N1 nodal metastasis is frequently missed. We tested the impact of corrective intervention with a novel pathology gross dissection protocol on intrapulmonary lymph node retrieval. This study is a retrospective review of consecutive lobectomy, or greater, lung resection specimens over a period of 15 months before and 15 months after training pathologist's assistants on the novel dissection protocol. One hundred forty one specimens were examined before and 121 specimens after introduction of the novel dissection protocol. The median number of intrapulmonary lymph nodes retrieved increased from 2 to 5 (P<.0001), and the 75th to 100th percentile range of detected intrapulmonary lymph node metastasis increased from 0 to 5 to 0 to 17 (P=.0003). In multivariate analysis, the extent of resection, examination period (preintervention or postintervention), and pathologic N1 (vs N0) status were most strongly associated with a higher number of intrapulmonary lymph nodes examined. A novel pathology dissection protocol is a feasible and effective means of improving the retrieval of intrapulmonary lymph nodes for examination. Further studies to enhance dissemination and implementation of this novel pathology dissection protocol are warranted.

摘要

尽管全面的病理淋巴结分期能为潜在可治愈的非小细胞肺癌患者提供最具预后价值的信息,但N1淋巴结转移却常常被漏诊。我们测试了采用一种新型病理大体解剖方案进行纠正干预对肺内淋巴结检出的影响。本研究是一项回顾性分析,纳入了在对病理科助理进行新型解剖方案培训前后各15个月期间连续的肺叶切除术或更大范围肺切除术标本。在引入新型解剖方案前检查了141个标本,引入后检查了121个标本。肺内淋巴结检出的中位数从2个增加到5个(P<0.0001),检测到的肺内淋巴结转移的第75至第100百分位数范围从0至5个增加到0至17个(P = 0.0003)。在多变量分析中,切除范围、检查时期(干预前或干预后)以及病理N1(相对于N0)状态与检查的肺内淋巴结数量增加最为密切相关。一种新型病理解剖方案是提高肺内淋巴结检出以供检查的可行且有效方法。有必要进一步开展研究以加强这种新型病理解剖方案的传播和实施。

相似文献

4
Dual intervention to improve pathologic staging of resectable lung cancer.双重干预以改善可切除肺癌的病理分期。
Ann Thorac Surg. 2013 Dec;96(6):1975-81. doi: 10.1016/j.athoracsur.2013.07.009. Epub 2013 Sep 23.

引用本文的文献

本文引用的文献

1
Towards optimal pathologic staging of resectable non-small cell lung cancer.实现可切除非小细胞肺癌最佳病理分期。
Transl Lung Cancer Res. 2013 Oct;2(5):364-71. doi: 10.3978/j.issn.2218-6751.2013.10.04.
4
Dual intervention to improve pathologic staging of resectable lung cancer.双重干预以改善可切除肺癌的病理分期。
Ann Thorac Surg. 2013 Dec;96(6):1975-81. doi: 10.1016/j.athoracsur.2013.07.009. Epub 2013 Sep 23.
10
Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.淋巴结数量和转移淋巴结比率与肺癌的生存有关。
Ann Thorac Surg. 2012 May;93(5):1614-9; discussion 1619-20. doi: 10.1016/j.athoracsur.2012.01.065. Epub 2012 Mar 20.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验